| Product NDC: | 52268-012 |
| Proprietary Name: | SUPREP Bowel Prep |
| Non Proprietary Name: | sodium sulfate, potassium sulfate, magnesium sulfate |
| Active Ingredient(s): | 1.6; 3.13; 17.5 g/mL; g/mL; g/mL & nbsp; sodium sulfate, potassium sulfate, magnesium sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52268-012 |
| Labeler Name: | Braintree Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022372 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100806 |
| Package NDC: | 52268-012-01 |
| Package Description: | 2 BOTTLE, PLASTIC in 1 CARTON (52268-012-01) > 177.4 mL in 1 BOTTLE, PLASTIC |
| NDC Code | 52268-012-01 |
| Proprietary Name | SUPREP Bowel Prep |
| Package Description | 2 BOTTLE, PLASTIC in 1 CARTON (52268-012-01) > 177.4 mL in 1 BOTTLE, PLASTIC |
| Product NDC | 52268-012 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sodium sulfate, potassium sulfate, magnesium sulfate |
| Dosage Form Name | SOLUTION, CONCENTRATE |
| Route Name | ORAL |
| Start Marketing Date | 20100806 |
| Marketing Category Name | NDA |
| Labeler Name | Braintree Laboratories, Inc. |
| Substance Name | MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
| Strength Number | 1.6; 3.13; 17.5 |
| Strength Unit | g/mL; g/mL; g/mL |
| Pharmaceutical Classes | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |